S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
NASDAQ:AIKI

AIkido Pharma Short Interest Ratio and Short Volume

$0.67
-0.03 (-3.87%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.66
$0.70
50-Day Range
$0.69
$0.91
52-Week Range
$0.55
$2.55
Volume
2.23 million shs
Average Volume
7.47 million shs
Market Capitalization
$60.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.41

AIkido Pharma (NASDAQ:AIKI) Short Interest Data

Current Short Volume
480,000 shares
Previous Short Volume
417,000 shares
Change Vs. Previous Month
+15.11%
Dollar Volume Sold Short
$376.13 thousand
Short Interest Ratio / Days to Cover
0.1
Last Record Date
November, 15 2021
Outstanding Shares
89,681,000 shares
Float Size
34,850,000 shares
Short Percent of Float
1.38%
Today's Trading Volume
2,229,959 shares
Average Trading Volume
7,465,690 shares
Today's Volume Vs. Average
-70.13%
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling AIkido Pharma ?

Sign up to receive the latest short interest report for AIkido Pharma and its competitors with MarketBeat's FREE newsletter.

AIkido Pharma (NASDAQ:AIKI) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/2021480,000 shares $376.13 thousand +15.1%1.4%0.1 $0.78
10/29/2021417,000 shares $371.76 thousand +281.5%1.2%0.1 $0.89
10/15/2021109,300 shares $91.05 thousand -83.9%0.3%0 $0.83
9/30/2021678,000 shares $558.60 thousand +43.5%2.0%0.2 $0.82
9/15/2021472,600 shares $358.66 thousand +1.2%1.4%0.4 $0.76
8/31/2021467,200 shares $385.44 thousand -23.2%1.3%0.3 $0.83
8/13/2021608,500 shares $492.28 thousand -6.8%1.8%0.3 $0.81
7/30/2021652,600 shares $571.81 thousand -8.8%1.9%0.3 $0.88
7/15/2021715,800 shares $610.51 thousand +2.2%2.1%0.3 $0.85
6/30/2021700,500 shares $670.38 thousand +36.9%2.0%0.2 $0.96
6/15/2021511,800 shares $537.39 thousand +94.8%1.5%0.1 $1.05
5/28/2021262,700 shares $281.09 thousand -34.4%0.8%0 $1.07
5/14/2021400,300 shares $340.86 thousand -41.4%1.2%0.1 $0.85
4/30/2021682,900 shares $689.73 thousand -29.2%2.0%0.1 $1.01
4/15/2021964,200 shares $926.50 thousand -51.6%2.8%0.1 $0.96
3/31/20211,990,000 shares $2.25 million +267.1%5.7%0.1 $1.13
3/15/2021542,100 shares $645.10 thousand -29.3%1.6%0 $1.19
2/26/2021766,800 shares $943.16 thousand +11.1%2.2%0 $1.23
2/12/2021690,400 shares $1.32 million -41.5%2.0%0 $1.91
1/29/20211,180,000 shares $1.68 million +2.6%3.4%0.1 $1.42
1/15/20211,150,000 shares $1.36 million No Change3.3%0.1 $1.18
2/28/2020241,000 shares $284.38 thousand +19,983.3%N/A0.1 $1.18
2/14/20201,200 shares $1.24 thousand -92.6%N/A0 $1.03
1/31/202016,100 shares $18.68 thousand +1,241.7%N/A0.4 $1.16
1/15/20201,200 shares $1.46 thousand -89.7%N/A0 $1.22













AIkido Pharma (NASDAQ:AIKI) Short Interest Frequently Asked Questions

What is AIkido Pharma's current short interest?

Short interest is the volume of AIkido Pharma shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 480,000 shares of AIKI short. 1.38% of AIkido Pharma's shares are currently sold short. Learn More on AIkido Pharma's current short interest.

What is a good short interest percentage for AIkido Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.38% of AIkido Pharma's floating shares are currently sold short.

Is AIkido Pharma's short interest increasing or decreasing?

AIkido Pharma saw a increase in short interest in November. As of November 15th, there was short interest totaling 480,000 shares, an increase of 15.1% from the previous total of 417,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is AIkido Pharma's float size?

AIkido Pharma currently has issued a total of 89,681,000 shares. Some of AIkido Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AIkido Pharma currently has a public float of 34,850,000 shares.

How does AIkido Pharma's short interest compare to its competitors?

1.38% of AIkido Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "commercial physical research" compare to AIkido Pharma: IQVIA Holdings Inc. (1.04%), Bitcoin Group SE (0.00%), Charles River Laboratories International, Inc. (1.63%), PPD, Inc. (13.07%), Incyte Co. (2.50%), ICON Public Limited (0.00%), Exact Sciences Co. (0.00%), Syneos Health, Inc. (0.00%), Medpace Holdings, Inc. (2.31%), and Anavex Life Sciences Corp. (9.90%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Railway Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short AIkido Pharma stock?

Short selling AIKI is an investing strategy that aims to generate trading profit from AIkido Pharma as its price is falling. AIkido Pharma's stock is trading down $0.03 today. To short AIkido Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that AIkido Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AIkido Pharma?

A short squeeze for AIkido Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AIKI, which in turn drives the price of the stock up even further.

How often is AIkido Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AIKI, twice per month. The most recent reporting period available is November, 15 2021.



This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.